European Journal of Chemistry

A new validated bio-analytical liquid chromatographic-tandem mass spectrometric (LC-MS/MS) method for the quantification of Azithromycin in human plasma

Article Sidebar

PDF
Published: Jun 30, 2014
DOI: https://doi.org/10.5155/eurjchem.5.2.241-246.1000
Keywords:
Azithromycin, Sildenafil citrate, Internal standard, Mass spectrometry, Liquid-liquid extraction, Liquid chromatography
Section
Research Article
Issue
Vol. 5 No. 2 (2014): June 2014
Dates
Received 2013-12-09
Accepted 2013-12-26
Published 2014-06-30


Main Article Content

Kareem Mahmoud Younes
Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, ET-11562, Egypt
Ehab Farouk El-Kady
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, ET-11562, Egypt

Abstract

A simple, rapid and sensitive LC-MS/MS method was developed and validated for the quantification of azithromycin (AZI) in human plasma. Sildenafil citrate was used as an internal standard. The analytes were extracted from human plasma samples by liquid-liquid extraction technique. The reconstituted samples were chromatographed on a reversed ‑ phase column C18, 50 × 2.1 mm, 5 µm from Waters, by using a 80:20 (v:v) mixture of acetonitrile and 0.1% formic acid in water as the mobile phase at a flow rate of 0.5 mL/min. The calibration curve was linear (r2 > 0.99) over the concentration range of 5.0-1500.0 ng/mL. The results of the intra- and inter-day precision and accuracy studies were within the acceptable limits. A run time of 0.5 min for each sample made it possible to analyze more than 400 plasma samples per day.


icon graph This Abstract was viewed 1918 times | icon graph Article PDF downloaded 1055 times

How to Cite
(1)
Younes, K. M.; El-Kady, E. F. A New Validated Bio-Analytical Liquid Chromatographic-Tandem Mass Spectrometric (LC-MS MS) Method for the Quantification of Azithromycin in Human Plasma. Eur. J. Chem. 2014, 5, 241-246.

Article Details

Author Biography

Kareem Mahmoud Younes, Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, ET-11562, Egypt

Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, ET-11562, Egypt

Share
Links for Article


Crossref - Scopus - Google - European PMC
Crossref
Scopus
Google Scholar
Europe PMC
References

[1]. Reynolds, J. E. F. (Ed.), Martindale: The Extra Pharmacopoeia, 36th edition, the Pharmaceutical Press, London, 2009, 207.

[2]. Ghodsi, R.; Kobarfard, K.; Tabatabai S. A. Iranian J. Pharm. Res. 2012, 11, 123-127.

[3]. Suhagia, B. N.; Shah, S. A.; Rathod, I. S.; Patel, H. M.; Doshi, K. R. Indian J. Pharm. Sci. 2006, 68, 242-245.
http://dx.doi.org/10.4103/0250-474X.25726

[4]. Mallah, M. A.; Sherazi, S. T. H.; Mahesar, S. A.; Rauf, A. Pak. J. Anal. Environ. Chem. 2011, 12, 61-67.

[5]. Khashaba, P. Y. J. Pharm. Biomed. Anal. 2002, 27, 923-932.
http://dx.doi.org/10.1016/S0731-7085(01)00609-4

[6]. Sastre, T. J.; Guchelaar, H. J. J. Chromatogr B. 1998, 720, 89-97.
http://dx.doi.org/10.1016/S0378-4347(98)00456-3

[7]. Bahrami, G.; Mirzae, S.; Kiani, A. J. Chromatogr B. 2005, 820, 277-281.
http://dx.doi.org/10.1016/j.jchromb.2005.03.042

[8]. Bahrami, G.; Mohammadi, B. J. Chromatogr B. 2006, 830, 355-358.
http://dx.doi.org/10.1016/j.jchromb.2005.10.044

[9]. Taninaka, C.; Ohtani, H.; Hanada, E.; Kotaki, H.; Sato, H.; Iga, T. J. Chromatogr B. 2000, 738, 405-411.
http://dx.doi.org/10.1016/S0378-4347(99)00512-5

[10]. Palomeque, M. E.; Ortiz, P. I. Talanta 2007, 72, 101-105.
http://dx.doi.org/10.1016/j.talanta.2006.10.002

[11]. Kees, F.; Spangler, S.; Wellenhofer, M. J. Chromatogr A. 1998, 812, 287-293.
http://dx.doi.org/10.1016/S0021-9673(97)01279-X

[12]. Shepard, R. M.; Duthu, G. S.; Ferraina, R. A.; Mullins, M. A. J. Chromatogr. 1991, 565 (1-2), 321-337.
http://dx.doi.org/10.1016/0378-4347(91)80393-Q

[13]. Gandhi, R.; Kaul, C. L.; Panchagnula, R. J. Pharmaceut. Biomed. Anal. 2000, 23, 1073-1078.
http://dx.doi.org/10.1016/S0731-7085(00)00406-4

[14]. Fouda, G. H.; Schneider, R. P. Ther. Drug Monit. 1995, 17, 179-183.
http://dx.doi.org/10.1097/00007691-199504000-00013

[15]. Abuin, S. O.; Codony, R.; Ramon, N. O.; Granados, M. E.; Dolors, P. M. J. Chromatogr A. 2006, 1114(1), 73-81.
http://dx.doi.org/10.1016/j.chroma.2006.02.032

[16]. Koch, D. E.; Bhandari, A.; Close, L.; Robert, P. H. J. Chromatogr A. 2005, 1074, 17-22.
http://dx.doi.org/10.1016/j.chroma.2005.03.052

[17]. Shen, Y.; Yin, C.; Mengxiang, S. U.; Jiasheng, T. U. J. Pharmaceut. Biomed. Anal. 2010, 52, 99-104.
http://dx.doi.org/10.1016/j.jpba.2009.12.001

[18]. Rockville, M. D. U. S. Pharmacopeia 35, National Formulary 30. The United States Pharmacopeial Commission Inc. 2010, 1965-1973.

[19]. Miguel, L.; Barbas, C. J. Pharm. Biomed. Anal. 2003, 33, 211-217.
http://dx.doi.org/10.1016/S0731-7085(03)00258-9

[20]. Patricia, Z.; Rita, C.; Maria, A. R.; Maria, T. P. J. Pharmaceut. Biomed. Anal. 2002, 27, 833-836.
http://dx.doi.org/10.1016/S0731-7085(01)00554-4

[21]. Tayebeh, G.; Farzad, K.; Seyed, A. M. Iranian J. Pharm. Res. 2013, 12, 57-63.

[22]. Hashemi, M. S. H.; Kobarfard, F.; Husain, S. W.; Tehrani, M. S.; Abroomand, A. P.; Ahmadkhanihac, R.; Mehdizadeh, A. Iranian J. Pharm. Res. 2012, 11, 59-67.

[23]. Fei, L.; Yu, X.; Jinchang, H.; Shu, G.; Qingxiang, G. Biomed Chromatogr. 2007, 21(12), 1272-1278.
http://dx.doi.org/10.1002/bmc.883

[24]. Xue-Min, Z.; Jie, L.; Juan, G.; Quan-Sheng, Y.; Wen-Yan, W. Pharmazie 2007, 62, 255-257.

[25]. Gobela, A.; Thomsena, A.; McArdella, C.; Aldera, A.; Gigera, W.; Theibb, N.; Lofflerb, D.; Ternes, T. J. Chromatog. A 2005, 1085(2), 179-189.
http://dx.doi.org/10.1016/j.chroma.2005.05.051

[26]. Chena, B.; Liangb, Y.; Chenc, X.; Liua, S.; Denga, F.; Zhoua, P. J. Pharm. Biomed. Anal. 2006, 42(4), 480-487.
http://dx.doi.org/10.1016/j.jpba.2006.05.011

[27]. Xu, F.; Zhang, Z.; Bian, Z.; Tian, Y.; Jiao, H.; Liu, Y. J. Chromatogr. Sci. 2008, 46, 479-484.
http://dx.doi.org/10.1093/chromsci/46.6.479

[28]. Supattanapong, S.; Konsil, J. Southeast Asian J. Trop. Med. Public Health 2008, 39(6), 979-987.

[29]. Hidy, B. J.; Lewis, J.; Ke, J. Proceedings of 50th ASMS Conference on Mass Spectrometry and Applied Topics, Orlando, Florida, 2002.

[30]. U.S. Department of Health and Human Services, Food and Drug Administration (US FDA). Guidance for Industry, Bioanalytical Method Validation. FDA/CDER/CVM, Federal Register, 2001, Available from: URL: http://www.fda.gov/cder/guidance/4252fnl.pdf

Supporting Agencies

The Holding Company for Biological Products and Vaccines (VACSERA), Cairo, Egypt
Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2025 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).